Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 2 (2005), Issue 8 (August)

1. NMR measurements of the diffusional permeability of water in cultured colonic epithelial cancer cells.
   Cell Biol Int, 29(6): 441-8. [Abstract] [Full-text]
2. Randomized clinical trial of the anabolic effect of hypocaloric parenteral nutrition after abdominal surgery.
   Br J Surg, 92(8): 947-53. [Abstract] [Full-text]
3. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
   Biochem Pharmacol, 70(5): 658-67. [Abstract] [Full-text]
4. Prediction of active drug plasma concentrations achieved in cancer patients by pharmacodynamic biomarkers identified from the geo human colon carcinoma xenograft model.
   Clin Cancer Res, 11(15): 5558-65. [Abstract] [Full-text]
5. RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer.
   Cancer Res, 65(15): 6882-90. [Abstract] [Full-text]
6. In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I.
   Bioorg Med Chem Lett, 15(17): 3930-3. [Abstract] [Full-text]
7. Dietary supplement of isohumulones inhibits the formation of aberrant crypt foci with a concomitant decrease in prostaglandin E2 level in rat colon.
   Mol Nutr Food Res, 49(8): 772-8. [Abstract] [Full-text]
8. Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1.
   J Cell Physiol, 205(1): 107-13. [Abstract] [Full-text]
9. Sulindac corrects defective apoptosis and suppresses azoxymethane-induced colonic oncogenesis in p53 knockout mice.
   Int J Cancer, 116(6): 870-5. [Abstract] [Full-text]
10. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas.
    Br J Cancer, 93(3): 338-45. [Abstract] [Full-text]
11. Effects of agmatine accumulation in human colon carcinoma cells on polyamine metabolism, DNA synthesis and the cell cycle.
    Biochim Biophys Acta, 1745(1): 111-23. [Abstract] [Full-text]
12. Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB.
    FEBS Lett, 579(20): 4213-8. [Abstract] [Full-text]
13. Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells.
    Oncology, 68(2): 204-11. [Abstract] [Full-text]
14. Collision/composite tumors of the adrenal gland: a pitfall of scintigraphy imaging and hormone assays in the detection of adrenal metastasis.
    J Clin Endocrinol Metab, 90(8): 4924-9. [Abstract] [Full-text]
15. Characteristics of apoptosis in HCT116 colon cancer cells induced by deoxycholic acid.
    J Biochem (Tokyo), 138(2): 151-7. [Abstract] [Full-text]
16. Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136.
    Eur J Cancer, 41(12): 1811-8. [Abstract] [Full-text]
17. Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymers.
    J Control Release, 106(1): 14-25. [Abstract] [Full-text]
18. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis.
    Gut, 54(9): 1287-92. [Abstract] [Full-text]
19. Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutations.
    Cancer Epidemiol Biomarkers Prev, 14(8): 2049-52. [Abstract] [Full-text]
20. 5,10-methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer.
    Cancer Epidemiol Biomarkers Prev, 14(8): 2023-9. [Abstract] [Full-text]
21. The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts.
    Cancer Res, 65(16): 7462-9. [Abstract] [Full-text]
22. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
    Cancer Res, 65(16): 7436-45. [Abstract] [Full-text]
23. Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death.
    Cancer Res, 65(16): 7403-12. [Abstract] [Full-text]
24. Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance.
    Cancer Res, 65(16): 7091-5. [Abstract] [Full-text]
25. Acid sphingomyelinase is induced by butyrate but does not initiate the anticancer effect of butyrate in HT29 and HepG2 cells.
    J Lipid Res, 46(9): 1944-52. [Abstract] [Full-text]
26. Explaining black-white differences in receipt of recommended colon cancer treatment.
    J Natl Cancer Inst, 97(16): 1211-20. [Abstract] [Full-text]
27. Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population.
    J Gastroenterol Hepatol, 20(9): 1410-5. [Abstract] [Full-text]
28. Adenomatous polyposis families that screen APC mutation-negative by conventional methods are genetically heterogeneous.
    J Clin Oncol, 23(24): 5651-9. [Abstract] [Full-text]
29. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
    J Clin Oncol, 23(24): 5635-43. [Abstract] [Full-text]
30. Distribution of lymph node metastasis in T1 sigmoid colon carcinoma: should we ligate the inferior mesenteric artery?
    Scand J Gastroenterol, 40(7): 858-61. [Abstract] [Full-text]
31. Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction.
    Colorectal Dis, 7(5): 492-5. [Abstract] [Full-text]
32. Impaired nonhomologous end-joining in mismatch repair-deficient colon carcinomas.
    Lab Invest, 85(9): 1130-8. [Abstract] [Full-text]
33. Self-expandable stents in malignant colonic obstruction: insertion assisted with a sphincterotome in technically difficult cases.
    Gastrointest Endosc, 62(3): 436-7. [Abstract] [Full-text]
34. Synthesis and evaluation of a DHA and 10-hydroxycamptothecin conjugate.
    Bioorg Med Chem, 13(19): 5592-9. [Abstract] [Full-text]
35. Proliferative signaling by store-operated calcium channels opposes colon cancer cell cytostasis induced by bacterial enterotoxins.
    J Pharmacol Exp Ther, 314(3): 1013-22. [Abstract] [Full-text]
36. Endoscopically controlled strictureplasty for stenotic colorectal anastomosis.
    Endoscopy, 37(9): 873-5. [Abstract] [Full-text]
37. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Clin Cancer Res, 11(16): 5950-5. [Abstract] [Full-text]
38. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Clin Cancer Res, 11(16): 5827-32. [Abstract] [Full-text]
39. The influence of gender on colon cancer stage.
    J Womens Health (Larchmt), 14(6): 502-6. [Abstract] [Full-text]
40. The initiation of colon cancer in a chronic inflammatory setting.
    Carcinogenesis, 26(9): 1513-9. [Abstract] [Full-text]
41. The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds.
    J Pediatr, 147(2): 263-6. [Abstract] [Full-text]
42. Colon cancer screening practices in New York City, 2003: results of a large random-digit dialed telephone survey.
    Cancer, 104(5): 1075-82. [Abstract] [Full-text]
43. Ribozymes targeting serine/threonine kinase Akt1 sensitize cells to anticancer drugs.
    Cancer Sci, 96(9): 620-6. [Abstract] [Full-text]
44. Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer.
    Ann Surg Oncol, 12(9): 733-42. [Abstract] [Full-text]
45. Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis.
    J Agric Food Chem, 53(18): 7320-9. [Abstract] [Full-text]
46. Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.
    Eur J Nucl Med Mol Imaging, 32(8): 901-9. [Abstract] [Full-text]
47. Radiofrequency ablation of colorectal liver metastases.
    Abdom Imaging, 30(4): 419-26. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.